Should segmentectomy indications be extended to NSCLC smaller than 3 cm without lymph node involvement? A retrospective single-center study - 09/07/25
, Soufiane Lebal b, Tristan Goudou a, Mihaela Giol a, Denis Debrosse a, Marielle LE Roux a, Thérésa Khalife-Hocquemiller a, Anna Vayssette a, Juliette Camuset a, Alexandra Rousseau b, Jalal Assouad a, Harry Etienne aGraphical abstract |
The 5-year event-free survival (recurrence or death) between lobectomy and segmentectomy
Abstract |
Introduction |
Surgical resection remains the standard treatment for stage IA non-small cell lung cancers (NSCLC). The dual objective of this study is to compare long-term outcomes of lobectomies and segmentectomies for stage IA NSCLC and to identify prognostic factors for resected stage IA NSCLC.
Materials and Methods |
This is a retrospective monocentric study including patients diagnosed with NSCLC smaller than 3 cm, without lymph node involvement, from November 2015 to November 2021. The primary endpoint was event-free survival (EFS), defined as time from surgery to recurrence or all-cause death. Secondary endpoints included overall survival, recurrence-free survival, and short-term postoperative outcomes (length of stay, drainage duration, 30-day mortality, and postoperative complications). Prognostic factors were analyzed using multivariate Cox regression adjusted for variables identified in univariate analysis.
Results |
A total of 457 patients underwent surgery for stage cIA NSCLC during the 11study period. Of these, 176 (38.5 %) had a segmentectomy, and 281 (61.5 %) underwent lobectomy. Among patients with cT1N0 tumors, the 5-year event-free survival did not significantly differ between the segmentectomy and lobectomy groups (adjusted HR = 0.59 (0.32; 1.08), p = 0.086), with 5-year event-free rates of 75.0 % and 83.0 %, respectively (p = 0.054). Multivariate analysis revealed an association between nodule type (solid vs. ground-glass or mixed) and event-free survival (death and/or recurrence) ([adjusted HR =2.07 (1.17–3.66), p = 0.01)]. Vascular and/or lymphatic invasion is associated with a decrease in event-free survival (recurrence or death) [adjusted HR = 2.25 (1.29; 3.92), p = 0.004]. Conversion from segmentectomy to lobectomy occurred in 6 patients (3.4 %), and they were included in the lobectomy group for analysis.
Conclusion |
For patients with clinical stage cIA NSCLC, segmentectomy appears to offer comparable oncologic outcomes to lobectomy. Tumor characteristics, including radiological appearance and histological factors, should be carefully considered when selecting the appropriate surgical strategy. Prospective multicenter studies are needed to confirm these findings.
Le texte complet de cet article est disponible en PDF.Keywords : Segmentectomy, Lobectomy, Non-small cell lung cancer, Event-free survival, Recurrence
Plan
Vol 88
Article 101179- novembre 2025 Retour au numéro
Article précédent
- Early mobilization and functional outcomes in cystic fibrosis patients after lung transplantation: A single-center retrospective study
- Matthieu Reffienna, Jeremy Roussel, Gabor Kalman, Mathilde Labro, Charles Cerf, François Parquin
- Does occupational exposure affect the surgical management of patients with non-small cell lung cancer? A single-center retrospective experience
- Matthieu Thumerel, Camille Carles, Hugues Begueret, Quentin Thomas, Jacques Jougon, Carine Audoin, Jean-François Bernaudin, Patrick Brochard, Yaniss Belaroussi
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?